Omega Fund Management, LLC Immunic, Inc. Transaction History
Omega Fund Management, LLC
- $48.5 Million
- Q1 2025
A detailed history of Omega Fund Management, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 1,788,160 shares of IMUX stock, worth $1.45 Million. This represents 4.02% of its overall portfolio holdings.
Number of Shares
1,788,160Holding current value
$1.45 Million% of portfolio
4.02%Shares
2 transactions
Others Institutions Holding IMUX
# of Institutions
74Shares Held
40.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$7.21 Million0.43% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.91 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.61 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.18 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.71 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $24.8M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...